𝔖 Bobbio Scriptorium

✦ LIBER ✦

Conversion to Silodosin in Men on Conventional α1-Blockers for Symptomatic Benign Prostatic Hyperplasia

✍ Scribed by Masahiko TANAKA; Aya NIIMI; Kyoichi TOMITA; Yukio HOMMA

Book ID: 118080640
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 502 KB
Volume: 2
Category: Article
ISSN: 1757-5664
DOI: 10.1111/j.1757-5672.2010.00055.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Silodosin, a new α1A-adrenoceptor-select

Silodosin, a new α1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men

✍ Kazuki Kawabe; Masaki Yoshida; Yukio Homma; for the Silodosin Clinical Study Gro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

A Systematic Review and Meta-analysis on

A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

✍ Mauro Gacci; Giovanni Corona; Matteo Salvi; Linda Vignozzi; Kevin T. McVary; Ste 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 451 KB

Corrigendum to “The Effects of Combinati

Corrigendum to “The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study” [Eur Urol 2010;57:123–31]

✍ Claus G. Roehrborn; Paul Siami; Jack Barkin; Ronaldo Damião; Kim Major-Walker; I 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Re: Mauro Gacci, Giovanni Corona, Matteo

Re: Mauro Gacci, Giovanni Corona, Matteo Salvi, et al. A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Eur Urol 2012;61:994–1003

✍ Jin-Qiu Yuan; Zu-Yao Yang; Chen Mao 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Reply to Jin-Qiu Yuan, Zu-Yao Yang, and

Reply to Jin-Qiu Yuan, Zu-Yao Yang, and Chen Mao's Letter to the Editor re: Mauro Gacci, Giovanni Corona, Matteo Salvi, et al. A Systematic Review and Meta-Analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Eur Urol 2012;61:994–1003: Meta-analysis on the Use of PDE5 Inhibitors for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia, According to the Recommendations of the Cochrane

✍ Mauro Gacci; Giovanni Corona; Matteo Monami; Sergio Serni; Vincenzo Mirone; Marc 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Reply to Stephen Shei-Dei Yang and Shang

Reply to Stephen Shei-Dei Yang and Shang-Jen Chang's Letter to the Editor re: Christopher R. Chapple, Francesco Montorsi, Teuvo L.J. Tammela, et al. Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe. Eur Urol 2011;59:342–52

✍ Christopher R. Chapple 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 71 KB